Innovative Drug to Treat Early Stage cALD Moves Into Phase 2 Nexus Trial Despite COVID
As reported by producer Minoryx; the pharmaceutical leriglitazone, used to treat early stage cerebral ALD (cALD) has just announced its plans to continue onto its Phase 2 Nexus trial without…